Recent advances in intestinal fibrosis
Copyright © 2024 Elsevier Ltd. All rights reserved..
Despite many progresses have been made in the treatment of inflammatory bowel disease, especially due to the increasing number of effective therapies, the development of tissue fibrosis is a very common occurrence along the natural history of this condition. To a certain extent, fibrogenesis is a physiological and necessary process in all those conditions characterised by chronic inflammation. However, the excessive deposition of extracellular matrix within the bowel wall will end up in the formation of strictures, with the consequent need for surgery. A number of mechanisms have been described in this process, but some of them are not yet clear. For sure, the main trigger is the presence of a persistent inflammatory status within the mucosa, which in turn favours the occurrence of a pro-fibrogenic environment. Among the main key players, myofibroblasts, fibroblasts, immune cells, growth factors and cytokines must be mentioned. Although there are no available therapies able to target fibrosis, the only way to prevent it is by controlling inflammation. In this review, we summarize the state of art of the mechanisms involved in gut fibrogenesis, how to diagnose it, and which potential targets could be druggable to tackle fibrosis.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:96 |
|---|---|
| Enthalten in: |
Molecular aspects of medicine - 96(2024) vom: 01. Apr., Seite 101251 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Lenti, Marco Vincenzo [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Collagen |
|---|
| Anmerkungen: |
Date Completed 11.03.2024 Date Revised 02.04.2024 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1016/j.mam.2024.101251 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM368497852 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM368497852 | ||
| 003 | DE-627 | ||
| 005 | 20240403000238.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240216s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.mam.2024.101251 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1361.xml |
| 035 | |a (DE-627)NLM368497852 | ||
| 035 | |a (NLM)38359700 | ||
| 035 | |a (PII)S0098-2997(24)00010-4 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Lenti, Marco Vincenzo |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Recent advances in intestinal fibrosis |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 11.03.2024 | ||
| 500 | |a Date Revised 02.04.2024 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Copyright © 2024 Elsevier Ltd. All rights reserved. | ||
| 520 | |a Despite many progresses have been made in the treatment of inflammatory bowel disease, especially due to the increasing number of effective therapies, the development of tissue fibrosis is a very common occurrence along the natural history of this condition. To a certain extent, fibrogenesis is a physiological and necessary process in all those conditions characterised by chronic inflammation. However, the excessive deposition of extracellular matrix within the bowel wall will end up in the formation of strictures, with the consequent need for surgery. A number of mechanisms have been described in this process, but some of them are not yet clear. For sure, the main trigger is the presence of a persistent inflammatory status within the mucosa, which in turn favours the occurrence of a pro-fibrogenic environment. Among the main key players, myofibroblasts, fibroblasts, immune cells, growth factors and cytokines must be mentioned. Although there are no available therapies able to target fibrosis, the only way to prevent it is by controlling inflammation. In this review, we summarize the state of art of the mechanisms involved in gut fibrogenesis, how to diagnose it, and which potential targets could be druggable to tackle fibrosis | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Review | |
| 650 | 4 | |a Collagen | |
| 650 | 4 | |a Crohn's disease | |
| 650 | 4 | |a Extracellular matrix | |
| 650 | 4 | |a Myofibroblast | |
| 650 | 4 | |a Strictureplasty | |
| 650 | 4 | |a Ulcerative colitis | |
| 700 | 1 | |a Santacroce, Giovanni |e verfasserin |4 aut | |
| 700 | 1 | |a Broglio, Giacomo |e verfasserin |4 aut | |
| 700 | 1 | |a Rossi, Carlo Maria |e verfasserin |4 aut | |
| 700 | 1 | |a Di Sabatino, Antonio |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Molecular aspects of medicine |d 1992 |g 96(2024) vom: 01. Apr., Seite 101251 |w (DE-627)NLM012681059 |x 1872-9452 |7 nnns |
| 773 | 1 | 8 | |g volume:96 |g year:2024 |g day:01 |g month:04 |g pages:101251 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.mam.2024.101251 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 96 |j 2024 |b 01 |c 04 |h 101251 | ||